5G SUCCEEDS
Research type
Research Study
Full title
Pilot study of developing 5G connected CCE home delivery system
IRAS ID
311685
Contact name
Ramesh Arasaradnam
Contact email
Sponsor organisation
UHCW NHS Trust, Research and Development Department
Duration of Study in the UK
0 years, 6 months, 1 days
Research summary
Research Summary:
Patients without alarming symptoms are at low risk of bowel cancer . However, in majority of those patients colonoscopy is needed to diagnose bowel conditions . Evaluation of patients in low-intermediate risk group represent significant pressure for colonoscopy services .In order to reduce potential diagnostic delays as a result of COVID pandemic , the role of colon capsule endoscopy (CCE) as a non invasive diagnostic test is being increasingly recognise, which allows for a pain-free colonic assessment by eliminating the need for instrument insertion, or sedation. At present in order to perform the CCE procedure it still requires patients to attend hospital. we are aiming by using 5G connected CCE home delivery system we will be able to reduce the colonoscopy waiting time and increase patients compliance and satisfaction while going through the investigation of bowel symptoms in the comfort of their own home.
Summary of Results:
The 5G SUCCEEDS project tested a new way of delivering a bowel test called Colon Capsule Endoscopy (CCE). In this test, patients swallow a small camera capsule that takes thousands of pictures of the bowel as it travels through. Traditionally, this test requires a hospital visit, but the project explored whether it could be delivered safely and effectively at home using 5G technology and digital innovation.
A total of 25 patients took part, selected from the NHS waiting list and GP referrals for colonoscopy – a routine test to check for bowel conditions. Each patient was sent a full home testing kit, courier-delivered to their home. This included the Inteligi GI Box, which contained all the equipment needed for the test — including the 5G-connected recording device and the capsule endoscopy components. Once the test was completed, the box was collected by courier and returned for analysis.
Before starting the test, patients had a telemedicine consultation with the clinical team. When they were ready to proceed, they were guided step-by-step through the process remotely. This included instructions on taking bowel preparation, swallowing the capsule, and wearing the recording device while going about their day at home.
The study showed the service was both feasible and well received. Most patients successfully completed the test, and over 90% were satisfied or very satisfied with the experience. They found it more convenient, less stressful, and appreciated avoiding hospital visits. The technology functioned reliably throughout.
This was the first UK study to show that bowel capsule tests can be safely done at home. It offers a promising way to reduce NHS waiting lists, lower carbon emissions from travel, and improve access to bowel diagnostics in the community.REC name
South Central - Hampshire A Research Ethics Committee
REC reference
22/SC/0236
Date of REC Opinion
25 Oct 2022
REC opinion
Further Information Favourable Opinion